| Novo Nordisk Pharma AG - Esperoct 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 67156 | | 01 | | Esperoct 500 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD02 | | Coagulation Factor Viii | | 30.07.2019 | | |
| | Composition | | Praeparatio cryodesiccata: turoctocogum alfa pegolum 500 U.I., histidinum, saccharum, polysorbatum 80, natrii chloridum corresp. natrium 14.16 mg, methioninum, calcii chloridum dihydricum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, pro vitro.
Solvens: natrii chloridum corresp. natrium 14.16 mg, aqua ad iniectabile q.s. ad solutionem pro 4 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 500 UI |
| | BAG: Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 500 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Calcium Chloride | | Histidine | | Methionine | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
| |
| Solvens | | | Lyophilisate and solvent | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 500 UI |
| | | | Inactive agents |
|---|
| Sodium Chloride |
| |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 500 UI |
| | BAG: Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 500 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum ad Ph | | Calcium Chloride | | Histidine | | Methionine | | Sodium Chloride | | Natrii Hydroxidum ad Ph | | Polysorbatum 80 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 373.19 | 423.95 | B | SL | Yes |
|
|
